Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||The HLDA8 blind panel: findings and conclusions|
|Citation:||Journal of Immunological Methods, 2005; 305(1):75-83|
|Publisher:||Elsevier Science BV|
|Bernadette Swart, Mikhail P. Salganik, Matthew P. Wand, Kathryn Tinckam, Edgar L. Milford, Karel Drbal, Pavla Angelisova, Vaclav Horejsi, Peter Macardle, Sheree Bailey, Enoc Hollemweguer, Greg Hodge, Judith Nairn, Debbrah Millard, Attila Dagdeviren, Geoffrey W. Dandie, Heddy Zola|
|Abstract:||There were over 600 antibodies submitted to HLDA8, with many of unknown specificity. Of these, 101 antibodies were selected for a blind panel study that also included 5 negative controls and 27 positive controls of known CD specificity making a total of 133 antibodies in the final panel. Of the 101 unknowns, 31 antibodies were identified during the course of this blind panel study as being specific for known molecules and included some specific for MHC class II antigens, CD45 isoforms and the Dombrock antigen. Several antibody pairs among those in the blind panel were found to have very similar staining patterns and were therefore compared by immunohistochemical and/or Western blot analyses for identity.|
|Keywords:||HLDA8 blind panel; Cell Line; Humans; Antigens, CD; Antibodies; Antigens, Surface; Blotting, Western; Immunochemistry; Antibody Specificity|
|Rights:||© 2005 Elsevier B.V. All rights reserved|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.